Fontacea shareholder Lei Meng, chairman of Shandong development investment holding group co. LTD

Mr Meng met with Mr Winnett on Jul 15, 2019. They talked about CNTO6785 project, exchanged views of international strategic cooperation in medicine area and achieved consensus on the bright prospection of the project.

Mark Winnett, the global strategy management consultant of Fontacea, is responsible for building strategic relationships with global pharmas. Launching new projects, researching and planning are also under his charge. Mr Winnett used to be the director of global strategic medicine development center in Johnson & Johnson, and the leader of CNTO6785 project. He is a widely acknowledged professional with 30 years experiences in R&D, biotechnology and medicine manufacturing, and many in-depth involvements in drug development across 6 countries.